Clinical Scorecard: Correction in Conclusions Section
At a Glance
| Category | Detail |
|---|
| Condition | Opioid Use Disorder (OUD) in Pregnancy |
| Key Mechanisms | Comparison of extended-release vs sublingual buprenorphine |
| Target Population | Pregnant adults with OUD |
| Care Setting | Clinical trial |
Key Highlights
- Higher rates of illicit opioid abstinence with extended-release buprenorphine
- Randomized clinical trial design
- Focus on pregnant adults
Guideline-Based Recommendations
Diagnosis
- Assess for opioid use disorder in pregnant patients
Management
- Consider extended-release buprenorphine for improved outcomes
Monitoring & Follow-up
- Monitor abstinence rates during treatment
Risks
- Potential for relapse if not properly managed
Patient & Prescribing Data
Pregnant adults with opioid use disorder
Extended-release buprenorphine may offer better abstinence rates
Clinical Best Practices
- Utilize evidence-based treatment options for OUD in pregnancy
- Regularly assess treatment efficacy and patient adherence
References
